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PRISMA 2009 Checklist 
Selection/Topic # Checklist Item Reported on 
Page # 
TITLE 
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1 
ABSTRACT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number. 
1 
INTRODUCTION 
Rationale 3 Described the rationale for the review in the context of what is already known 3 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
6 
METHODS 
Protocol and 
registration 
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
n/a 
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving rationale. 
6 
Information sources 7 Described all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional 
studies in the search and date last searched. 
7 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. 7 
Supplementary 
data 
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included 
in the meta-analysis). 
8 
Data collection 
process 
10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators. 
8 
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
8 
Risk of bias in 
individual studies 
12 Described methods used for assessing risk of bias of individual studies (including specification of whether this was done at 
the study or outcome level), and how this information is to be used in any data synthesis.  
8 
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 9 
Synthesis of results 14 Described the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., 
I2) for each meta-analysis. 
9 
Risk of bias across 
studies 
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting 
within studies). 
8 
Supplementary 
data 
Additional analyses 16 Described methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified. 
n/a 
PRISMA 2009 Checklist 
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusion at each 
stage, ideally with a flow diagram. 
8 
Supplementary 
data 
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
8 
Risk of bias within 
studies 
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). Supplementary 
data 
Results of individual 
studies 
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally within a forest plot. 
8 
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 9 
Risk of bias across 
studies 
22 Present the results of any assessment of risk of bias across studies (see item 15). Supplementary 
data 
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see item 16]). n/a 
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key 
groups (e.g., healthcare providers, users, and policy makers). 
11 
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
15 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research 15 & 16 
FUNDING 
Funding  27 Described sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review. 
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 Figure S1: Adapted PRISMA 2009 Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching  
n = 1,856 
Additional records identified through 
Hand Search of reference lists, Pubmed 
similarity and Google 
(n = 240) 
Total records reviewed  
(n = 2,096) 
Records screened  
(n = 198) 
Records excluded  
(n = 159) 
Full-text articles assessed 
for eligibility  
(n = 39) 
Full-text articles excluded, 
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(n = 27) 
Studies included in 
quantitative synthesis 
(meta-analysis)  
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 Table S1: Search Terms 
 
 
Fertility Decisions  HIV Positive 
Subheading/MeS
H Term Free Text 
Subheading/MeSH 
Term Free Text 
childbearing 
motivation childbearing 
motivation* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AND 
 
 
 
 
Human 
Immunodeficiency 
Virus 
Human 
Immunodeficiency 
Virus 
OR childbearing 
desires 
OR 
childbearing 
desire* OR HIV OR HIV 
OR childbearing 
intentions 
OR 
childbearing 
intention* 
OR HIV Clinical 
Care 
OR HIV Clinical 
Care 
0R childbearing 
decisions  
OR 
childbearing 
decision* OR HIV-1 OR HIV-1 
OR pregnancy 
desires 
OR pregnancy 
desire* 
OR Human 
Immunodeficiency 
Virus 1 
OR Human 
Immunodeficiency 
Virus 1 
OR pregnancy 
intentions 
OR pregnancy 
intention* 
OR HIV-Infected 
Patients 
OR HIV-Infected 
Patients 
OR pregnancy 
motivations 
OR pregnancy 
motivation* 
OR HIV Positive 
Patients 
OR HIV Positive 
Patients 
OR fertility 
(exploded) OR fertil* 
OR HIV 
Seropositivity 
OR HIV 
Seropositiv* 
OR Intention 
OR fertility 
intention 
OR Antiretroviral 
Therapy, Highly 
Active 
OR Highly Active 
Antiretroviral 
Therapy 
OR fertility desires 
OR fertility 
desire* OR HAART OR HAART 
OR fertility 
decisions 
OR fertility 
decision*   
OR Pregnancy OR Pregnancy 
OR Antiretroviral 
Therapy 
OR Antiretroviral 
Therapy 
OR reproductive 
counselling  
OR 
reproductive 
counselling  
 
OR preconception 
counselling 
OR 
preconception 
counselling 
OR pregnancy 
care 
OR 
preconception 
care 
OR family 
planning family planning 
 Figure S2: Funnel Plot of Women Who Already Have At Least One Child 
 
 
Table S2: Risk Of Bias Assessment, Adapted From Higgins & Green (2011) 
Red = High risk of bias, Yellow = Unclear, Green = Low 
 
 
 
 
Domain O1 O2 O3 O4 O5 O6 O7 O8 O9 O10 O11 O12 
Bias due to confounding                         
Bias in selection of 
participants into the 
study                         
Bias in measurements of 
interventions 
(observations)                         
Bias due to departure 
from intended 
interventions  n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 
Bias due to missing data                         
Bias in measurement of 
outcomes                         
Bias in selection of the 
reported result                         
Overall Risk of Bias                         
 Figure S3: Funnel Plot of Women Who Want To Have A Child 
 
 
 
 
 
 
